BriaCell shareholders ratify auditor, elect six directors, approve equity plan at AGM

BriaCell Therapeutics Corp.

MNP LLP ratified as auditor with 3,431,761 for, 70,934 against.
Six directors elected: Gross, Bondarenko, Williams, Taub, Embro-Pantalony, Schmieg. For votes ranged from ~1.837M to ~1.848M.
Omnibus equity incentive plan re-approved: 1,524,081 for, 362,949 against (51% of shares voted).

item 5.07

BriaCell Therapeutics Corp. filing history →

Source: SEC EDGAR

accession 0001493152-26-009382

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.